After adjustment for the covariates outlined in Table 2, levels of both serum CRP and serum CRPM were found to be significantly higher in the MS-RA cohort, and significantly lower in the OA cohort as compared to the E-RA cohort (Table 3, supplementary (S) Table S1). Here, SH3BP2 is linked to myeloid sarcoma.